TEPYLUTE
LIVE

Serial Number

98211536

Owner

Shorla Pharma Limited

Attorney

Sean P. McMahon

Filing Date

Oct 5, 2023

Add to watchlist:

No watchlists yet
View on USPTO

TEPYLUTE Trademark

Serial Number: 98211536 • Registration: 7658017

TEPYLUTE is a trademark filed by Shorla Pharma Limited on October 5, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Shorla Pharma Limited (11 trademarks)

Questum Acceleration Centre
Clonmel, Co. Tipperary E91V239 , IE

Entity Type: 99

Trademark Details

Filing Date

October 5, 2023

Registration Date

January 21, 2025

Published for Opposition

December 3, 2024

Goods & Services

Pharmaceutical and medicinal preparations and substances for the treatment of metabolic diseases and disorders, oncological diseases and disorders, dermatological diseases and disorders, hormonal diseases and disorders, viral diseases and disorders, bacterial diseases and disorders, infectious diseases and disorders, viral diseases and disorder, as well as diseases and disorders of the alimentary tract, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system, and respiratory system; pharmaceutical and medicinal preparations and substances for use in oncology; pharmaceutical preparations, products and substances for human use for the treatment of metabolic diseases and disorders, oncological diseases and disorders, dermatological diseases and disorders, hormonal diseases and disorders, viral diseases and disorders, bacterial diseases and disorders, infectious diseases and disorders, viral diseases and disorder, as well as diseases and disorders of the alimentary tract, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system, and respiratory system; pharmaceutical preparations and substances for the prevention and treatment of cancer; pharmaceutical compounds for treating cancer; biological preparations for the treatment of cancer; pharmaceutical preparations and substances for the prevention of tumours; anti-cancer drugs and pharmaceutical preparations

Research and development services in the field of metabolic diseases and disorders, oncological diseases and disorders, dermatological diseases and disorders, hormonal diseases and disorders, viral diseases and disorders, bacterial diseases and disorders, infectious diseases and disorders, viral diseases and disorder, as well as diseases and disorders of the alimentary tract, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system, and respiratory system; biological research; scientific research services; research and development services in the pharmaceutical and biotechnology fields; research services relating to the development and testing of pharmaceutical preparations and medicines; pharmaceutical drug development services; pharmaceutical product evaluation; testing and inspection of pharmaceutical preparations and medicines; product safety and quality testing in the pharmaceutical and biotechnology fields; provision of information and data relating to research and development in the pharmaceutical and biotechnology fields

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 21, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 21, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 3, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 3, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 27, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 5, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 4, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 4, 2024 CRFA
ASSIGNED TO LIE
Nov 4, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 8, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 12, 2024 GNRN
NON-FINAL ACTION E-MAILED
May 12, 2024 GNRT
NON-FINAL ACTION WRITTEN
May 12, 2024 CNRT
ASSIGNED TO EXAMINER
May 10, 2024 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 25, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 25, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 25, 2024 REAP
NOTICE OF DESIGN SEARCH CODE E-MAILED
Oct 17, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 14, 2023 NWOS